Stock listing
Frankfurt:BHM Bachem Holding AG Aktie
German listing (Frankfurt) of Bachem Holding AG · home listing SIX Swiss:BANB
Follow Bachem Holding AG into a list and get an email when it puts out news.
Share price · FWB:BHM
€10.22 EUR +0.08 (+0.8%)
Close on Nov 5, 2026
- Day range
- €10.22 – €10.22 EURNov 5, 2026
- Market cap
- €7.66B EURAt the close on Nov 5, 2026 · price × 749.4M shares outstanding
- 52-week range
- €4.61 – €10.30 EURLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- €30 EURMedian day 0 shares · 64 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BANB · Home | 76.20 CHF | -3.15 (-4.0%) | 173,479 | 79.05 | 79.75 | 75.40 | 79.35 | Close on Nov 20, 2026 |
| LSE:0QND | 76.40 CHF | -3.45 (-4.3%) | 13,740 | 79.60 | 79.60 | 75.60 | 79.85 | Close on Nov 20, 2026 |
| OTC:BCHMY | $9.00 USD | -0.19 (-2.1%) | 100 | $9.00 | $9.00 | $9.00 | $9.19 | Close on Nov 20, 2026 |
| Frankfurt:BHM | €10.22 EUR | +0.082 (+0.8%) | — | €10.22 | €10.22 | €10.22 | €10.14 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · FWB:BHM · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €10.22 | +0.082 | +0.8% | €10.22 | €10.22 | €10.22 | 0 | |
| €10.14 | -0.007 | -0.1% | €10.14 | €10.14 | €10.14 | 0 | |
| €10.14 | +0.027 | +0.3% | €10.14 | €10.14 | €10.14 | 0 | |
| €10.12 | -0.072 | -0.7% | €10.12 | €10.12 | €10.12 | 0 | |
| €10.19 | +0.026 | +0.3% | €10.19 | €10.19 | €10.19 | 0 | |
| €10.16 | -0.013 | -0.1% | €10.16 | €10.16 | €10.16 | 0 | |
| €10.18 | -0.071 | -0.7% | €10.18 | €10.18 | €10.18 | 0 | |
| €10.25 | +0.097 | +1.0% | €10.25 | €10.25 | €10.25 | 0 | |
| €10.15 | -0.071 | -0.7% | €10.15 | €10.15 | €10.15 | 0 | |
| €10.22 | +0.038 | +0.4% | €10.22 | €10.22 | €10.22 | 0 | |
| €10.18 | +0.006 | +0.1% | €10.18 | €10.18 | €10.18 | 0 | |
| €10.18 | +2.078 | +25.7% | €8.211 | €10.30 | €8.068 | 4 | |
| €8.098 | +0.095 | +1.2% | €7.955 | €8.102 | €7.908 | 0 | |
| €8.003 | -0.01 | -0.1% | €8.003 | €8.053 | €7.897 | 0 | |
| €8.013 | +0.133 | +1.7% | €7.968 | €8.018 | €7.884 | 0 | |
| €7.88 | +0.203 | +2.6% | €7.713 | €7.923 | €7.65 | 0 | |
| €7.677 | +0.134 | +1.8% | €7.693 | €7.744 | €7.677 | 0 | |
| €7.543 | -0.083 | -1.1% | €7.548 | €7.549 | €7.543 | 0 | |
| €7.626 | +0.145 | +1.9% | €7.47 | €7.635 | €7.392 | 0 | |
| €7.481 | +0.077 | +1.0% | €7.478 | €7.497 | €7.379 | 0 | |
| €7.404 | -0.151 | -2.0% | €7.404 | €7.404 | €7.404 | 0 | |
| €7.555 | -0.204 | -2.6% | €7.513 | €7.613 | €7.506 | 0 | |
| €7.759 | +0.363 | +4.9% | €7.673 | €7.794 | €7.62 | 0 | |
| €7.396 | +0.008 | +0.1% | €7.396 | €7.396 | €7.396 | 0 | |
| €7.388 | +0.051 | +0.7% | €7.296 | €7.389 | €7.252 | 0 | |
| €7.337 | -0.28 | -3.7% | €7.381 | €7.382 | €7.337 | 0 | |
| €7.617 | +0.051 | +0.7% | €7.62 | €7.707 | €7.609 | 0 | |
| €7.566 | -0.059 | -0.8% | €7.565 | €7.572 | €7.56 | 0 | |
| €7.625 | +0.056 | +0.7% | €7.648 | €7.659 | €7.565 | 0 | |
| €7.569 | -0.091 | -1.2% | €7.691 | €7.738 | €7.50 | 0 | |
| €7.66 | -0.122 | -1.6% | €7.788 | €7.865 | €7.616 | 0 | |
| €7.782 | +0.149 | +2.0% | €7.792 | €7.82 | €7.733 | 0 | |
| €7.633 | +0.247 | +3.3% | €7.552 | €7.68 | €7.521 | 0 | |
| €7.386 | +0.169 | +2.3% | €7.373 | €7.487 | €7.363 | 248 | |
| €7.217 | +0.002 | 0.0% | €7.28 | €7.312 | €7.173 | 0 | |
| €7.215 | +0.063 | +0.9% | €7.194 | €7.217 | €6.866 | 0 | |
| €7.152 | +0.049 | +0.7% | €7.159 | €7.163 | €7.146 | 0 | |
| €7.103 | -0.136 | -1.9% | €7.112 | €7.144 | €7.097 | 20 | |
| €7.239 | +0.18 | +2.5% | €7.224 | €7.256 | €7.208 | 0 | |
| €7.059 | -0.261 | -3.6% | €7.335 | €7.423 | €7.00 | 0 | |
| €7.32 | +0.216 | +3.0% | €7.342 | €7.465 | €7.289 | 0 | |
| €7.104 | -0.143 | -2.0% | €7.139 | €7.192 | €7.065 | 0 | |
| €7.247 | +0.179 | +2.5% | €7.208 | €7.299 | €7.207 | 0 | |
| €7.068 | -0.128 | -1.8% | €7.066 | €7.113 | €7.063 | 0 | |
| €7.196 | -0.163 | -2.2% | €7.377 | €7.419 | €7.178 | 0 | |
| €7.359 | +0.268 | +3.8% | €7.226 | €7.388 | €7.181 | 0 | |
| €7.091 | +0.015 | +0.2% | €7.011 | €7.139 | €6.996 | 0 | |
| €7.076 | -0.039 | -0.5% | €7.076 | €7.083 | €7.073 | 0 | |
| €7.115 | -0.038 | -0.5% | €7.115 | €7.125 | €6.965 | 0 | |
| €7.153 | +0.057 | +0.8% | €7.132 | €7.168 | €7.077 | 0 | |
| €7.096 | -0.028 | -0.4% | €7.02 | €7.136 | €6.98 | 0 | |
| €7.124 | -0.022 | -0.3% | €7.174 | €7.213 | €7.031 | 0 | |
| €7.146 | -0.073 | -1.0% | €7.11 | €7.146 | €7.083 | 0 | |
| €7.219 | +0.002 | 0.0% | €7.225 | €7.245 | €7.181 | 0 | |
| €7.217 | -0.069 | -0.9% | €7.233 | €7.292 | €7.131 | 0 | |
| €7.286 | +0.17 | +2.4% | €7.385 | €7.402 | €7.277 | 0 | |
| €7.116 | +0.173 | +2.5% | €6.946 | €7.189 | €6.881 | 0 | |
| €6.943 | -0.058 | -0.8% | €6.961 | €7.083 | €6.872 | 0 | |
| €7.001 | +0.035 | +0.5% | €7.001 | €7.001 | €7.001 | 0 | |
| €6.966 | +0.025 | +0.4% | €6.976 | €7.019 | €6.963 | 0 | |
| €6.941 | +0.113 | +1.7% | €6.906 | €6.958 | €6.906 | 0 | |
| €6.828 | -0.427 | -5.9% | €6.828 | €6.828 | €6.828 | 0 | |
| €7.255 | -0.017 | -0.2% | €7.255 | €7.255 | €7.255 | 0 | |
| €7.272 | -0.012 | -0.2% | €7.272 | €7.272 | €7.272 | 0 | |
| €7.284 | -0.047 | -0.6% | €7.284 | €7.284 | €7.284 | 0 | |
| €7.331 | +0.055 | +0.8% | €7.331 | €7.331 | €7.331 | 0 | |
| €7.276 | -0.008 | -0.1% | €7.276 | €7.276 | €7.276 | 0 |
- Ticker
- Frankfurt:BHM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Jul 30, 2026
Bachem Confirms Growth and Expects a Strong Second Half 2026
Latest earnings call · Jul 30, 2026
Bachem Holding (SIX Swiss: BANB) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 30, 2026
H1 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Bachem Confirms Growth and Expects a Strong Second Half 2026
Jul 30, 2026
Closed €7.11 (-0.4%) on Jul 30, 2026
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
Jul 21, 2026
Closed €7.24 (+7.8%) on Jul 21, 2026
Bachem Holding AG Announces Capital Markets Day 2026
Jun 12, 2026
Closed €6.35 (-10.5%) on Jun 15, 2026
Bachem Announces Changes to the Corporate Executive Committee
May 5, 2026
Closed €7.09 (+2.4%) on May 5, 2026
Bachem Annual General Meeting 2026
Apr 29, 2026
Closed €6.69 (+3.6%) on Apr 30, 2026
Bachem Secures Financing of Strategic Growth Initiatives
Apr 27, 2026
Closed €6.56 (+1.4%) on Apr 27, 2026
Bachem inaugurates Building K in Bubendorf, strengthening large-scale production of modern APIs
Apr 24, 2026
Closed €6.47 (+0.2%) on Apr 24, 2026
Bachem Reports Strong Sales Growth and Sustained High Profitability
Mar 12, 2026
Closed €5.87 (+9.3%) on Mar 12, 2026
Bachem Holding AG on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 10 in the last 12 months · 21 in all · newest Jul 30, 2026 · oldest 2024
- Calls
- 2 calls with a replay · 2 with a transcript · latest Jul 30, 2026
- Decks
- 14 decks · latest Jul 30, 2026
Where Bachem Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BANB · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QND | LSE | United Kingdom | CHF |
| gettex:BHM0 | gettex | Germany | EUR |
| OTC:BCHMY | OTC | United States | USD |
| OTC:BCHMF | OTC | United States | USD |
| Tradegate:BHM0 | Tradegate | Germany | EUR |
| Aquis:BANBZ | Aquis | United Kingdom | CHF |
| BX Swiss:BANB | BX Swiss | Switzerland | CHF |
| LS Exchange:A3DLKE | LS Exchange | Germany | EUR |
| Frankfurt:BHM · This page | Frankfurt | Germany | EUR |
| Frankfurt:BHM0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A3DLKE | Lang & Schwarz | Germany | EUR |
| BMV:BANBN | BMV | Mexico | MXN |
| Dusseldorf:BHM0 | Dusseldorf | Germany | EUR |
| Munich:BHM0 | Munich | Germany | EUR |
| Stuttgart:BHM0 | Stuttgart | Germany | EUR |
| Turquoise:BANBZ | Turquoise | United Kingdom | CHF |
| BIVA:BANBN | BIVA | Mexico | MXN |
| Dusseldorf:BHM | Dusseldorf | Germany | EUR |
Valuation
P/E 38.4× against a median of 35.3×: 4th lowest of 7 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 5.87B CHF
- P/E
- 38.4×
- EV/sales
- 8.4×
- EV/EBITDA
- 29.7×
- Price/book
- 4.0×
- Gross margin
- 28.7%
- Operating margin
- 21.6%
- Net margin
- 21.4%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bachem Holding AG Class B · SIX:BANB | US$6.80B | US$6.99B | 38.4× | 8.4× | 29.7× | 4.0× | 21.4% | 0.1× | n/a |
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.54B | US$8.25B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.53B | US$7.12B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Twist Bioscience Corporation · NASDAQ:TWST | US$7.04B | US$6.46B | n/a | 14.1× | n/a | 7.9× | −28.3% | 0.0× | 2.77 |
| Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821 | US$6.85B | US$5.90B | 38.5× | 5.3× | n/a | 2.6× | 15.9% | 0.0× | n/a |
| 10x Genomics, Inc. · NASDAQ:TXG | US$6.29B | US$5.79B | n/a | 9.4× | n/a | 7.5× | −10.8% | 0.1× | 2.34 |
| Anthem Biosciences Limited · NSE:ANTHEM | US$5.78B | US$5.71B | 87.3× | 25.9× | 62.5× | 16.3× | 30.0% | 0.0× | n/a |
| Caris Life Sciences, Inc. · NASDAQ:CAI | US$4.97B | US$4.60B | 51.7× | 4.4× | 28.3× | 7.8× | 9.2% | 0.6× | 1.90 |
| Median of the others | US$7.29B | US$6.79B | 35.3× | 6.6× | 62.5× | 4.5× | 10.1% | 0.1× | 1.90 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 84.30 CHF · Analysts' mean
- EPS, year to Dec 2026
- 2.41 · 9 analysts
- Revenue, year to Dec 2026
- 944M · 6 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Anne-Kathrin Stoller | Chief Executive Officer (CEO) |
| Alain Schaffter | Chief Financial Officer (CFO) |
| Hans van Hees | Chief Operations Officer (COO) |
| Barbora Blaha | Head Investor Relations |
| Boris Corpataux | Chief Commercial Officer (CCO) |
| Günther Loidl | Chief Technology Officer (CTO) |
Board
| Director | Role |
|---|---|
| Kuno Sommer | Chairman |
| Nicole Grogg Hötzer | Vice-Chairwoman |
Events
- Next results
- Mar 4, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Bachem Holding (SIX Swiss: BANB) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:00 AM ET | Replay |
| Bachem Holding (SIX Swiss: BANB) Q4 2025 Earnings Call | Thu, Mar 12, 2026 · 6:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Dec 31, 2025 | −2.4% |
| Quarter to Sep 30, 2025 | Dec 3, 2025 | +0.5% |
| Q2 2025 | Jul 24, 2025 · After close | −0.7% |
| Quarter to Mar 31, 2025 | May 28, 2025 | +0.6% |
| Q4 2024 | Feb 20, 2025 | +2.1% |
| Quarter to Sep 30, 2024 | Nov 27, 2024 | +0.6% |
| Q2 2024 | Jul 25, 2024 | −8.9% |
| Quarter to Mar 31, 2024 | May 29, 2024 | −2.8% |
| Q4 2023 | Mar 7, 2024 | +16.9% |
| Quarter to Sep 30, 2023 | Nov 29, 2023 | +2.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Jul 27, 2023 · After close | −1.6% |
| Quarter to Mar 31, 2023 | May 31, 2023 | −1.5% |
| Q4 2022 | Mar 7, 2023 · After close | +0.7% |
| Q3 2022 | Nov 30, 2022 | +2.7% |
| Q2 2022 | Aug 25, 2022 · After close | −2.1% |
| Q1 2022 | Jun 1, 2022 | +0.5% |
| Q4 2021 | Mar 18, 2022 · Before open | −9.2% |
| Q3 2021 | Dec 1, 2021 | −5.9% |
| Q2 2021 | Aug 27, 2021 | 0.0% |
| Q1 2021 | Jun 2, 2021 | −0.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 24 slides | Jul 30, 2026 |
| FY2025 Earnings Presentation | Earnings | 31 slides | Mar 12, 2026 |
| J.P. Morgan 44th Annual Healthcare Conference 2026 | Conference | 21 slides | Jan 14, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 21 slides | Jan 14, 2026 |
| Investor Day (November 2024) | Investor day | 40 slides | Nov 21, 2024 |
| FY2023 Earnings Presentation | Earnings | 30 slides | Mar 7, 2024 |
| Investor Day (2024) | Investor day | 22 slides | 2024 |
| H1 2023 Earnings Presentation | Earnings | 24 slides | Jul 27, 2023 |
| FY2022 Earnings Presentation | Earnings | 32 slides | Mar 7, 2023 |
| Investor Day (September 2022) | Investor day | 36 slides | Sep 20, 2022 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2021 Earnings Presentation | Earnings | 28 slides | Mar 18, 2022 |
| Investor Presentation (September 2021) | Investor deck | 26 slides | Sep 23, 2021 |
| H1 2021 Earnings Presentation | Earnings | 26 slides | Aug 27, 2021 |
| FY2020 Earnings Presentation | Earnings | 27 slides | Mar 12, 2021 |
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 695.1M | 605.3M | 577.3M | 531.7M | 503.2M | 402.0M | 313.7M | 282.5M | 261.6M | 236.5M |
| Cost of revenue | 495.3M | 422.7M | 400.4M | 360.5M | 336.5M | 273.1M | 221.2M | 199.3M | 178.9M | 159.2M |
| Gross profit | 199.7M | 182.6M | 177.0M | 171.3M | 166.7M | 128.9M | 92.5M | 83.2M | 82.7M | 77.2M |
| Research and development | 10.2M | 11.4M | 11.0M | 7.20M | 3.82M | 2.94M | 1.66M | 1.76M | 1.97M | 1.56M |
| Selling, general and administrative | 23.3M | 21.8M | 19.4M | 19.0M | 16.9M | 14.6M | 13.6M | 13.9M | 18.0M | 17.6M |
| Operating income | 150.3M | 133.0M | 129.4M | 126.3M | 128.0M | 95.8M | 61.4M | 54.8M | 50.2M | 45.1M |
| Depreciation and amortization | 47.4M | 43.3M | 37.4M | 33.3M | 28.4M | 25.9M | 24.9M | 23.1M | 20.9M | 19.7M |
| EBITDA | 197.7M | 176.3M | 166.7M | 159.6M | 156.5M | 121.7M | 86.3M | 77.9M | 71.1M | 64.8M |
| Interest expense | 484.0K | 292.0K | 367.0K | 719.0K | 798.0K | 591.0K | 495.0K | 614.0K | 441.0K | 347.0K |
| Income before tax | 156.4M | 135.2M | 124.2M | 112.1M | 131.4M | 91.0M | 60.4M | 54.6M | 48.4M | 45.9M |
| Income tax | 7.61M | 15.0M | 12.3M | 11.4M | 16.7M | 12.9M | 6.21M | 7.99M | 6.60M | 4.68M |
| Net income | 148.8M | 120.2M | 111.9M | 100.7M | 114.7M | 78.1M | 54.2M | 46.6M | 41.8M | 41.2M |
| Earnings per share, basic | 1.98 | 1.60 | 1.50 | 1.37 | 1.62 | 1.12 | 0.78 | 0.69 | 0.62 | 0.61 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 31.0M | 95.2M | 157.7M | 31.5M | 89.2M | 23.5M | 21.4M | 22.3M | 17.3M | 19.2M |
| Short-term investments | 0 | 140.8M | 237.0M | 353.2M | ||||||
| Receivables | 188.2M | 273.3M | 200.3M | 179.3M | 114.8M | 80.9M | 87.6M | 85.3M | 58.0M | 52.2M |
| Inventory | 494.4M | 450.2M | 341.0M | 308.0M | 272.4M | 245.2M | 219.2M | 195.6M | 172.7M | 151.9M |
| Current assets | 726.8M | 822.8M | 841.5M | 760.4M | 833.7M | 352.5M | 331.2M | 305.4M | 251.2M | 225.8M |
| Property, plant and equipment | 1.33B | 1.06B | 814.6M | 599.8M | 445.7M | 340.3M | 296.6M | 289.8M | 274.5M | 255.3M |
| Total assets | 2.11B | 1.92B | 1.68B | 1.38B | 1.30B | 710.9M | 647.1M | 614.7M | 544.7M | 496.5M |
| Accounts payable | 41.8M | 72.9M | 29.1M | 32.1M | 25.0M | 25.5M | 18.2M | 9.90M | 17.7M | 19.7M |
| Current liabilities | 405.5M | 281.0M | 164.7M | 164.8M | 134.6M | 137.5M | 104.3M | 194.3M | 136.2M | 99.5M |
| Long-term debt | 0 | 0 | 0 | 60.1M | 60.0M | 284.0K | 188.0K | 302.0K | ||
| Total debt | 57.4M | 290.0K | 401.0K | 691.0K | 20.9M | 107.6M | 107.1M | 150.5M | 94.9M | 55.4M |
| Total liabilities | 650.4M | 531.9M | 362.4M | 214.2M | 177.5M | 235.2M | 199.3M | 230.5M | 170.5M | 131.1M |
| Shareholders' equity | 1.46B | 1.39B | 1.32B | 1.17B | 1.12B | 475.7M | 447.8M | 384.2M | 374.2M | 365.4M |
| Shares outstanding | 75.0M | 75.0M | 74.7M | 73.7M | 70.8M | 70.0M | 69.2M | 67.9M | 67.9M | 67.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 271.4M | 146.3M | 249.9M | 92.6M | 97.6M | 115.0M | 64.3M | 25.8M | 36.5M | 40.4M |
| Capital spending | -319.6M | -284.6M | -268.4M | -142.3M | -116.8M | -69.1M | -30.6M | -33.8M | -45.7M | -49.2M |
| Free cash flow | -48.2M | -138.3M | -18.5M | -49.7M | -19.3M | 45.9M | 33.7M | -8.06M | -9.26M | -8.76M |
| Cash from investing | -325.2M | -148.9M | -170.8M | -63.2M | -469.1M | -69.3M | -30.6M | -38.1M | -46.1M | -51.3M |
| Cash from financing | -9.52M | -61.3M | 48.7M | -87.0M | 437.2M | -43.1M | -34.3M | 17.5M | 7.74M | 7.22M |
| Dividends paid | -30.7M | -60.0M | -56.2M | -51.6M | -20.5M | -42.0M | -27.4M | -27.4M | -23.9M | -20.5M |
| Share buybacks | -2.87M | -1.06M | -585.0K | -1.44M | -898.0K | -1.00M | 47.1M | 0 | 52.7M | 17.1M |
| Change in cash | -64.2M | -62.5M | 126.3M | -57.7M | 65.7M | 2.06M | -871.0K | 5.02M | -1.92M | -4.04M |
Cap table
Built by 6ix from Bachem Holding AG Class B’s releases
- Common shares
- 74,935,540
- Fully diluted
- 74,935,540
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 74,935,540 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 74,935,540 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alain Schaffter | Chief Financial Officer (CFO) · Since at least Jun 12, 2026 |
| Anne-Kathrin Stoller | Chief Executive Officer (CEO) · Since at least Jul 30, 2026 |
| Barbora Blaha | Head Investor Relations · Since at least Jul 30, 2026 |
| Boris Corpataux | Chief Commercial Officer (CCO) · Since at least Jul 30, 2026 |
| Günther Loidl | Chief Technology Officer (CTO) · Since at least Nov 21, 2024 |
| Hans van Hees | Chief Operations Officer (COO) · Since at least Aug 20, 2025 |
| Kuno Sommer | Chairman · Since at least May 5, 2026 |
| Nicole Grogg Hötzer | Vice-Chairwoman · Since at least Apr 29, 2026 |
Log in to ask 6ix AI your own questions about Bachem Holding AG.